Mycapssa
20 mg · Capsule, Delayed Release
- Prescription only
- Somatostatin Analog
- Active substance
- Octreotide
- Made by
- Amryt Pharmaceuticals Designated Activity Company
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
BulgariaNo exact match for this strength and form
European UnionNo exact match for this strength and form
Details
| Made by | Amryt Pharmaceuticals Designated Activity Company |
|---|---|
| Active substance | Octreotide |
| Used in | Heart, blood pressure and circulation |
| Strength | 20 mg |
| Form | Capsule, Delayed Release |
| Route | Oral |
| Packs | 4 BLISTER PACK in 1 DOSE PACK / 7 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK |
| NDC | 69880-120 |
Source: NDC Directory · 2026-09-13 · not reviewed by a clinician
Source: US Food and Drug Administration, NDC Directory. Reuse terms: US government work (FDA).
Other strengths and forms
2 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- Capsule, Delayed Release2 products
20 mg2
20 mg · 2 companies
- Amryt Pharmaceuticals Designated Activity Company · this page
- Chiesi USA, Inc.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.